LYEL stock

Lyell Immunopharma Inc (LYEL) financials · rev $36.0K

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Lyell Immunopharma Inc (LYEL) rev $36.0K.

Cached annual income statement
LineFY2025FY2024
Revenue$36.0K$61.0K
Operating Income-$269.4M-$358.8M
Net Income-$274.4M-$343.0M
EPS (Diluted)-$16.06-$1.31
Cached annual balance sheet
LineFY2025FY2024
Total Assets$340.1M$490.9M
Current Assets$260.9M$379.6M
Cash & Equivalents$60.2M$105.6M
PP&E$34.8M$48.2M
Total Liabilities$91.8M$108.0M
Current Liabilities$49.4M$53.8M
Shareholders' Equity$248.2M$382.8M
Retained Earnings-$1.62B-$1.35B
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$150.0M-$162.4M
CapEx$780.0K$464.0K
Investing Cash Flow$54.1M$122.4M
Financing Cash Flow$50.4M$1.33M
Net Change in Cash-$45.5M-$38.6M
Free Cash Flow-$150.8M-$162.9M
These statements as JSON? API free 100/day

FAQ

What is LYEL P/E and revenue?

Lyell Immunopharma Inc (LYEL) rev $36.0K.

What is LYEL revenue?

Lyell Immunopharma Inc last cached revenue is $36.0K (FY2025).

Is LYEL profitable?

Lyell Immunopharma Inc last cached net income is -$274.4M (FY2025).

What are LYEL total assets?

Lyell Immunopharma Inc last cached total assets are $340.1M (FY2025).

What is LYEL free cash flow?

Lyell Immunopharma Inc last cached free cash flow is -$150.8M (FY2025).

Not investment advice. Cached statements, not a live tape.